Fog/Mist 44°
Tag:

Paxlovid

Politics
COVID-19: Biden Tests Positive, Has 'Mild Symptoms' COVID-19: Biden Tests Positive, Has 'Mild Symptoms'
Covid-19: Biden Tests Positive, Has 'Mild Symptoms' President Joe Biden has tested positive for COVID-19, the White House announced on Thursday morning, July 21. The 79-year-old Biden, who is fully vaccinated and double boosted, is "experiencing very mild symptoms," the White House says. Biden tested posted after a trip to Somerset, Massachusetts on Wednesday, July 20. Biden has begun taking the therapeutic Paxlovid, the White House said. "Consistent with CDC guidelines, he will isolate at the White House and will continue to carry out all of his duties fully during that time," the White House said. "He has been in contact with members of …

SHARE

by Joe Lombardi
Business
COVID-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication COVID-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication
Covid-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication Stop & Shop has begun offering two approved COVID-19 antiviral medicines, Pfizer's Paxlovid and Merck's Molnupiravir at its 55 New York pharmacies. The mega-supermarket chain made the announcement on Thursday, April 7, that the drugs would be available at no cost with a valid prescription from a health care provider. The COVID-19 anti-viral medication Molnupiravir can be prescribed to those 18 and older, while Paxlovid is authorized for use by adults and children ages 12 and older weighing at least 88 pounds, store officials said. Availability of the anti-viral oral prescript…

SHARE

by Kathy Reakes
News
COVID-19: FDA OKs First Authorized Home Treatment For Virus COVID-19: FDA OKs First Authorized Home Treatment For Virus
Covid-19: FDA OKs First Authorized Home Treatment For Virus The fight against COVID-19 took a step forward as federal health officials authorized the first pill that Americans will be able to take at home to head off the worst effects of the virus. On Wednesday, Dec. 22, the US Food and Drug Administration (FDA) granted emergency authorization for Pfizer’s COVID-19 treatment pill, which has been recommended for people at high risk of developing severe cases of COVID-19. The pill could be available as soon as this weekend, according to Pfizer CEO Albert Bourla. Related story - COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effective…

SHARE

by Zak Failla
News
COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effectiveness Vs. Omicron, Severe Disease COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effectiveness Vs. Omicron, Severe Disease
Covid-19: Pfizer Releases Data On Anti-Viral Pill's Effectiveness Vs. Omicron, Severe Disease Brand-new laboratory studies are shedding light on the effectiveness of Pfizer's anti-viral COVID-19 pill both against the Omicron variant and in warding off severe disease. The studies showed the pill, called Paxlovid, reduced the risk of hospitalization or death by nearly 90 percent if given to high-risk adults within several days of their initial COVID symptoms, Pfizer said in a statement released Tuesday morning, Dec. 14. The pill also retains activity against variants, including Omicron, because the drug blocks an enzyme involved in viral replication, Pfizer said. “Emerging …

SHARE

by Joe Lombardi
News
COVID-19: Pfizer CEO Says New Vaccine May Be Needed For Omicron, Anti-Viral Pills Are Effective COVID-19: Pfizer CEO Says New Vaccine May Be Needed For Omicron, Anti-Viral Pills Are Effective
Covid-19: Pfizer CEO Says New Vaccine May Be Needed For Omicron, Anti-Viral Pills Are Effective Pfizer CEO Albert Bourla said that his company is preparing to tackle new COVID-19 variants, and that he expects the company’s treatment pill will be effective in helping avoid severe illness or possibly death if one get infected. According to the World Health Organization (WHO), Omicron poses a “very high” global risk, with the likelihood it is more transmissible than previous strains. The new variant has nearly three dozen mutations that reportedly decrease antibody protection. WHO described Omicron as a “highly divergent variant with a high number of mutations ... some of which are conce…

SHARE

by Zak Failla